Quick-Med Technologies, Inc. focuses on sustainable antimicrobial technologies. It provides treatment optimization, laboratory prototyping to factory scale-up, domestic and international regulatory guidance, microbiological efficacy testing including viruses, patent expertise, technology evaluations, antimicrobials market evaluations, and scientific invention and original research products. The company's core technologies include Nimbus, a non-leaching antimicrobial wound dressing material; Stay Fresh, a sequestered hydrogen peroxide-based antimicrobial technology; and superabsorbent antimicrobial materials. In addition, it offers bioguard, DriGo-HP, antimicrobial care products, antimicrobial textiles, and antimicrobial paints and coatings products. Quick-Med Technologies, Inc. was incorporated in 1997 and is headquartered in Gainesville, Florida.
Frequently asked questions
What sector does Quick-Med Technologies Inc (QMDT) operate in?
Quick-Med Technologies Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Quick-Med Technologies Inc (QMDT) current stock price?
As of the latest data, Quick-Med Technologies Inc stock price is $0.00, with a previous close of $0.00.
What is Quick-Med Technologies Inc (QMDT) current market capitalization?
Quick-Med Technologies Inc market cap is approximately 18.67 thousand.
Does Quick-Med Technologies Inc (QMDT) pay dividends?
No. Quick-Med Technologies Inc does not pay a dividend.
What is Quick-Med Technologies Inc (QMDT) beta (volatility) score?
Quick-Med Technologies Inc has a beta of -80.312, indicating lower volatility than the overall market.